Cargando…

Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study

BACKGROUND: Essential hypertension (EH) is influenced by various environmental and genetic factors. Nitric oxide is important for the functional integrity of the vascular endothelium and is produced in endothelial cells by the enzyme endothelial nitric oxide synthase (eNOS). EH has a strong genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamil, Sahar, Erdmann, Jeanette, Abdalrahman, Ihab B., Mohamed, Abdelrahim O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683550/
https://www.ncbi.nlm.nih.gov/pubmed/29132319
http://dx.doi.org/10.1186/s12881-017-0491-7
_version_ 1783278308259004416
author Gamil, Sahar
Erdmann, Jeanette
Abdalrahman, Ihab B.
Mohamed, Abdelrahim O.
author_facet Gamil, Sahar
Erdmann, Jeanette
Abdalrahman, Ihab B.
Mohamed, Abdelrahim O.
author_sort Gamil, Sahar
collection PubMed
description BACKGROUND: Essential hypertension (EH) is influenced by various environmental and genetic factors. Nitric oxide is important for the functional integrity of the vascular endothelium and is produced in endothelial cells by the enzyme endothelial nitric oxide synthase (eNOS). EH has a strong genetic component, and the NOS3 gene, which encodes eNOS, represents an interesting candidate for contribution to the phenotype. The most clinically relevant polymorphisms in the NOS3 gene are rs1799983 in exon 7 (encoding Glu298Asp), a variable number tandem repeat (VNTR) in intron 4, and rs2070744 (T-786C) in the promoter region. This study aims to investigate the association between these three polymorphisms in the NOS3 gene and EH in Sudanese patients. METHODS: Hypertensive patients (n = 157) > 18 years of age with established hypertension from various hospitals in Khartoum, and controls (n = 85) > 18 years of age and with blood pressure measurements <140/90, were included in this case control study. Genotypes at the NOS3 variants were determined using TaqMan and polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analyses. Genotype and allele frequencies were compared between the two groups by χ(2) analysis, and differences were expressed as odds ratios with 95% confidence intervals (CIs). P values <0.05 were considered statistically significant. RESULTS: The rs2070744 polymorphism in NOS3 was found to be associated with EH in the Sudanese population as the patients group had higher frequency of CC genotype compared with the controls (6.6% vs 6.1%, p = 0.02). Considering a dominant inheritance model, the frequency of TC + CC genotypes in patients was significantly higher than that in the control subjects (52.6% vs 34.1%, respectively; p < 0.01), with an odds ratio (95% CI) of 2.14 (1.23–3.74). In addition, the C allele was more frequent in the patients than the control group (29.6% vs 20%, p = 0.03, OR = 1.84 (1.15–2.93)). The c allele of intron 4 VNTR was reported in >1% of the Sudanese population under study. CONCLUSION: The results of this study indicated that the rs2070744 polymorphism in NOS3 may be a genetic susceptibility factor for EH in the Sudanese population. The c allele of intron 4 VNTR is not rare in the Sudanese population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-017-0491-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5683550
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56835502017-11-20 Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study Gamil, Sahar Erdmann, Jeanette Abdalrahman, Ihab B. Mohamed, Abdelrahim O. BMC Med Genet Research Article BACKGROUND: Essential hypertension (EH) is influenced by various environmental and genetic factors. Nitric oxide is important for the functional integrity of the vascular endothelium and is produced in endothelial cells by the enzyme endothelial nitric oxide synthase (eNOS). EH has a strong genetic component, and the NOS3 gene, which encodes eNOS, represents an interesting candidate for contribution to the phenotype. The most clinically relevant polymorphisms in the NOS3 gene are rs1799983 in exon 7 (encoding Glu298Asp), a variable number tandem repeat (VNTR) in intron 4, and rs2070744 (T-786C) in the promoter region. This study aims to investigate the association between these three polymorphisms in the NOS3 gene and EH in Sudanese patients. METHODS: Hypertensive patients (n = 157) > 18 years of age with established hypertension from various hospitals in Khartoum, and controls (n = 85) > 18 years of age and with blood pressure measurements <140/90, were included in this case control study. Genotypes at the NOS3 variants were determined using TaqMan and polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analyses. Genotype and allele frequencies were compared between the two groups by χ(2) analysis, and differences were expressed as odds ratios with 95% confidence intervals (CIs). P values <0.05 were considered statistically significant. RESULTS: The rs2070744 polymorphism in NOS3 was found to be associated with EH in the Sudanese population as the patients group had higher frequency of CC genotype compared with the controls (6.6% vs 6.1%, p = 0.02). Considering a dominant inheritance model, the frequency of TC + CC genotypes in patients was significantly higher than that in the control subjects (52.6% vs 34.1%, respectively; p < 0.01), with an odds ratio (95% CI) of 2.14 (1.23–3.74). In addition, the C allele was more frequent in the patients than the control group (29.6% vs 20%, p = 0.03, OR = 1.84 (1.15–2.93)). The c allele of intron 4 VNTR was reported in >1% of the Sudanese population under study. CONCLUSION: The results of this study indicated that the rs2070744 polymorphism in NOS3 may be a genetic susceptibility factor for EH in the Sudanese population. The c allele of intron 4 VNTR is not rare in the Sudanese population. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-017-0491-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-13 /pmc/articles/PMC5683550/ /pubmed/29132319 http://dx.doi.org/10.1186/s12881-017-0491-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gamil, Sahar
Erdmann, Jeanette
Abdalrahman, Ihab B.
Mohamed, Abdelrahim O.
Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title_full Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title_fullStr Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title_full_unstemmed Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title_short Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study
title_sort association of nos3 gene polymorphisms with essential hypertension in sudanese patients: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683550/
https://www.ncbi.nlm.nih.gov/pubmed/29132319
http://dx.doi.org/10.1186/s12881-017-0491-7
work_keys_str_mv AT gamilsahar associationofnos3genepolymorphismswithessentialhypertensioninsudanesepatientsacasecontrolstudy
AT erdmannjeanette associationofnos3genepolymorphismswithessentialhypertensioninsudanesepatientsacasecontrolstudy
AT abdalrahmanihabb associationofnos3genepolymorphismswithessentialhypertensioninsudanesepatientsacasecontrolstudy
AT mohamedabdelrahimo associationofnos3genepolymorphismswithessentialhypertensioninsudanesepatientsacasecontrolstudy